--- schema_version: "secwatch.filing_event.v1" accession: "0000885590-23-000021" form_type: "8-K" ticker: "BHC" cik: "0000885590" company_name: "Bausch Health Companies Inc." filed_at: "2023-05-17T23:59:59+00:00" generated_at: "2026-06-14T22:55:11.243508+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.1 calibrated_materiality_score: 0.1 confidence: "high" source: SEC EDGAR --- # Bausch Health shareholders elect all 10 directors, approve say-on-pay and incentive plan amendment ## Summary - All 10 director nominees elected; Thomas Appio received 190.9M votes for, B. Icahn 169.7M. - Say-on-pay approved (178M for, 15.1M against, 629K abstain); future votes set annually. - Amendment to 2014 Omnibus Incentive Plan approved (171.2M for, 22.6M withheld) increasing authorized shares. - PwC reappointed as independent auditor (260.5M for, 2.5M withheld). - Broker non-votes of 69.2M shares on proposals 1-3 did not affect outcome. ## SEC filing metadata - accession: 0000885590-23-000021 - form_type: 8-K - ticker: BHC - cik: 0000885590 - company_name: Bausch Health Companies Inc. - filed_at: 2023-05-17T23:59:59+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.1 - calibrated_materiality_score: 0.1 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/0000885590-23-000021-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/bhc-20230517.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0000885590-23-000021 - JSON: https://secwatch.observer/filing/0000885590-23-000021.json - Plain text: https://secwatch.observer/filing/0000885590-23-000021.txt ## Key facts - Shareholder Votes Bausch Health Companies Inc. shareholders approved Appointment of the Independent Registered Public Accounting Firm at the 2023-05-16 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-05-16 source text: The shareholders appointed PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2024 Annual Meeting of Shareholders and authorized the Company’s Board of Directors to fix the auditors’ remuneration. For Withheld 260,531,419 2,470,470 evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/0000885590-23-000021-index.htm - Shareholder Votes Bausch Health Companies Inc. shareholders approved Advisory Vote on Executive Officer Compensation at the 2023-05-16 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-05-16 source text: The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Proxy Statement. For Against Abstain Broker Non-Votes 178,033,723 15,117,579 629,322 69,221,265 evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/0000885590-23-000021-index.htm - Shareholder Votes Bausch Health Companies Inc. shareholders approved Advisory Vote on Frequency of Future Advisory Votes on Executive Officer Compensation at the 2023-05-16 meeting. - Proposal: say on pay frequency - Outcome: passed - Meeting: 2023-05-16 source text: The shareholders approved, on a non-binding advisory basis, the frequency of the shareholder vote to approve the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Proxy Statement. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 190,477,720 616,376 2,187,370 499,158 69,221,265 evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/0000885590-23-000021-index.htm - Shareholder Votes Bausch Health Companies Inc. shareholders approved Election of Directors at the 2023-05-16 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-05-16 source text: The shareholders elected the following individuals to the Company’s Board of Directors, to serve until the close of the Company’s 2024 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director’s earlier resignation or removal: Name For Withheld Broker Non-Votes Thomas J. Appio 190,930,071 2,850,553 69,221,265 Brett M. Icahn 169,686,359 24,094,265 69,221,265 Sarah B. Kavanagh 189,301,790 4,478,834 69,221,265 Steven D. Miller 181,093,705 12,686,919 69,221,265 Dr. Richard C. Mulligan 174,330,012 19,450,612 69,221,265 John A. Paulson 182,711,655 11,068,969 69,221,265 Robert N. Power 183,421,864 10,358,760 69,221,265 Russel C. Robertson 189,249,474 4,531,150 69,221,265 Thomas W. Ross, Sr. 190,210,369 3,570,255 69,221,265 Amy B. Wechsler, M.D. 190,174,239 3,606,385 69,221,265 evidence_url: https://www.sec.gov/Archives/edgar/data/885590/000088559023000021/0000885590-23-000021-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.